CARDIAC TROPONIN- T: A SPECIFIC BIOCHEMICAL MARKER OF MYOCARDIAL DYSFUNCTION, MO

$10,643M01FY2010RRNIH

Lundquist Institute For Biomedical Innovation At Harbor-Ucla Medical Center, Torrance CA

Investigators

Linked publications & trials

Paper 39397778 Paper 38880394 Paper 38746373 Paper 38547955 Paper 38236978 Paper 38222977 Paper 38190104 Paper 38160309 Paper 37910437 Paper 37777948 Paper 37662185 Paper 37659258 Paper 37338666 Paper 36780383 Paper 36540980 Paper 36128629 Paper 35472396 Paper 35244151 Paper 35175842 Paper 35113658 Paper 34966880 Paper 34752621 Paper 34728061 Paper 34570768 Paper 34528718 Paper 34460319 Paper 34166655 Paper 34161253 Paper 34038937 Paper 33901188 Paper 33662486 Paper 33545261 Paper 33270715 Paper 33202262 Paper 33066718 Paper 32984497 Paper 32936208 Paper 32928740 Paper 32803094 Paper 32578481 Paper 32556630 Paper 32492107 Paper 32458454 Paper 32375556 Paper 32268814 Paper 32226820 Paper 32063125 Paper 32063062 Paper 32037132 Paper 31957961 Paper 31940010 Paper 31884245 Paper 31859580 Paper 31772544 Paper 31714576 Paper 31564163 Paper 31547912 Paper 31490202 Paper 31448444 Paper 31404422 Paper 31058466 Paper 31056078 Paper 30976755 Paper 30888919 Paper 30801985 Paper 30661700 Paper 30496407 Paper 30487263 Paper 30470724 Paper 30370022 Paper 30341055 Paper 30336817 Paper 30293664 Paper 30214855 Paper 30041793 Paper 29985202 Paper 29920702 Paper 29762147 Paper 29738414 Paper 29670744 Paper 29575061 Paper 29459474 Paper 29263019 Paper 29217675 Paper 29150290 Paper 29103858 Paper 29081724 Paper 28938457 Paper 28931566 Paper 28607128 Paper 28605043 Paper 28428055 Paper 28158423 Paper 28109970 Paper 28081214 Paper 27618452 Paper 27507809 Paper 27438329 Paper 27267867 Paper 27190099

Abstract

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The purpose of this study is to establish whether heart function in very low birth weight infants can be predicted by a simple blood test and whether this serial measurements of this test can predict overall outcome in very low birth infants .This blood test has been done in adults to detect damage in adults. It is hoped that this test will allow us to detect heart damage in very low birth infants earlier and provide us with more details on their long term outcome. This study will help us in better understanding of the heart function in very low birth weight infants and may provide a reliable blood test to not only monitor heart function but also to predict the ultimate outcome in very low birth weight infants. The babies enrolled will be lesser than 1500 gm. Pregnant women admitted to the hospital who have an estimated fetal weight <1500 g will be approached for informed consent for enrollment prior to delivery. If we are unable to approach mother prior to delivery, she will be approached after the delivery for enrollment. They will have special heart scans to look at their heart four times during the first week (Days 1,2,3, and 7 after delivery and at 1 month of age). Heart scans are routinely performed to detect heart problems in NICUs, and majority of very low birth infants have multiple heart scans performed during their stay in the NICU.

View original record on NIH RePORTER →